Company to receive $7.0 million up front for its preclinical oncology drug candidate Up to $130.0 million in milestone payments starting with initiation of Phase 1 High single digit royalties that ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...

Through nifty marketing and an insurance-circumventing subscription model that delivers medicine directly to your front door, ...

The price of weight loss drugs is falling, making them more accessible to consumers, and the price could get driven even lower.Highly sought-after drugs like Wegovy and Zepbound both retail at roughly ...

He spotted the opportunity to invest in weight-loss drugs in 2023 before they exploded in 2024, and was an early AI mover, which he spied as a game changer in late 2022, early 2023. It's all about ...

MarketSmith India is a stock research platform and advisory service focused on the Indian stock market.

J. M. Smucker's fundamentals remain steady. Technically, shares are range-bound and lack momentum. Click here to read why I ...

Continuing high prices and demand for GLP-1 weight-loss drugs is creating lots of questions about the affordability of these drugs for U.S. healthcare consumers. For more than two years ...

Drugmakers are introducing discounts and lower-cost options for consumers who have to pay for GLP-1 drugs out of pocket. News outlets look at the trend in pricing for drugs like Wegovy and Zepbound.

31,136 people played the daily Crossword recently. Can you solve it faster than others?31,136 people played the daily Crossword recently. Can you solve it faster than others?